Advances in Therapeutic Monitoring of Lithium in the Management of Bipolar Disorder
Since the mid-20th century, lithium continues to be prescribed as a first-line mood stabilizer for the management of bipolar disorder (BD). However, lithium has a very narrow therapeutic index, and it is crucial to carefully monitor lithium plasma levels as concentrations greater than 1.2 mmol/L are...
Main Authors: | Mahsa Sheikh, Meha Qassem, Iasonas F. Triantis, Panicos A. Kyriacou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Sensors |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8220/22/3/736 |
Similar Items
-
Therapeutic monitoring of mood stabilizers in bipolar disorder
by: D. Falfel, et al.
Published: (2021-04-01) -
Lithium monitoring in clinical practice
by: E. Sciberras, et al.
Published: (2021-04-01) -
External Evaluation of Population Pharmacokinetics Models of Lithium in the Bipolar Population
by: Lereclus Aurélie, et al.
Published: (2023-11-01) -
A 5-Year Study of Lithium and Valproic Acid Drug Monitoring in Patients with Bipolar Disorders in an Italian Clinical Center
by: Marco Carli, et al.
Published: (2022-01-01) -
Lithium treatment and estimate glomerular filtration rate in bipolar disorder patients: A cross-sectional study
by: S. Fernandes, et al.
Published: (2021-04-01)